CD&A
Richard Nixon
Oliver Sander, Statistical Methodology & Consulting, Novartis
PSI conference, London
May 2017
Influence
• Scientific / academic influence
• Applied / industry influence
• Personal influence
CD&A
2
Business Use Only
Measuring scientific influence
CD&A
3
Business Use Only
Influencing co-authors
Benefitrisk
Cambridge
cluster-rand.
Deborah
Ashby
MRC / LSHTM
Cost-eff.
Simon
Thompson
MRC / Sheffield
RA, Network MA
Richard
NVS
arthritis MA & BR
NVS
network MA, HE
hypertension
NVS
Network MA
MRC
MS
MS
Macular
edema
CD&A
4
Business Use Only
Influencing other papers
146
citations
>2000 total
citations
CD&A
5
Business Use Only
Indirect influence
Nixon 2007
Network meta-regression
Cited by 147
Salanti 2008
Network meta-analysis
Cited by 484
PRISMA 2009
Meta-analysis guidelines
Cited by 9991
CD&A
6
Business Use Only
Applied / industry influence
Decision analysis, structured
benefit-risk, milestone decisions
Decision analysis
CD&A
8
Business Use Only
Benefit-risk
Quantitative tollgate
Decision analysis, structured
benefit-risk, milestone decisions
Decision analysis
Framework applied
across many projects,
including clinical, health
economics, operational,
manufacturing, etc.
CD&A
9
Business Use Only
Benefit-risk
Included in 7 submissions
~35 moderators trained
>1000 associates trained
Quantitative tollgate
Expected for all
projects at phase
transitions
(2a  2b,
2b  3,
3  submission)
Personal influence
Collaborating / mentoring / teaching
CD&A
11
Business Use Only
CD&A
12
Business Use Only
Thank you